SG11201810031RA - Microorganism with modified aldehyde:ferredoxin oxidoreductase activity and related methods - Google Patents

Microorganism with modified aldehyde:ferredoxin oxidoreductase activity and related methods

Info

Publication number
SG11201810031RA
SG11201810031RA SG11201810031RA SG11201810031RA SG11201810031RA SG 11201810031R A SG11201810031R A SG 11201810031RA SG 11201810031R A SG11201810031R A SG 11201810031RA SG 11201810031R A SG11201810031R A SG 11201810031RA SG 11201810031R A SG11201810031R A SG 11201810031RA
Authority
SG
Singapore
Prior art keywords
international
aldehyde
lamon
skokie
avenue
Prior art date
Application number
SG11201810031RA
Other languages
English (en)
Inventor
Fungmin Liew
Michael Koepke
Original Assignee
Lanzatech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lanzatech Inc filed Critical Lanzatech Inc
Publication of SG11201810031RA publication Critical patent/SG11201810031RA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0006Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0008Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P5/00Preparation of hydrocarbons or halogenated hydrocarbons
    • C12P5/007Preparation of hydrocarbons or halogenated hydrocarbons containing one or more isoprene units, i.e. terpenes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P5/00Preparation of hydrocarbons or halogenated hydrocarbons
    • C12P5/02Preparation of hydrocarbons or halogenated hydrocarbons acyclic
    • C12P5/026Unsaturated compounds, i.e. alkenes, alkynes or allenes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • C12P7/06Ethanol, i.e. non-beverage
    • C12P7/065Ethanol, i.e. non-beverage with microorganisms other than yeasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • C12P7/16Butanols
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436Fatty acid esters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y102/00Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
    • C12Y102/01Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)
    • C12Y102/0101Acetaldehyde dehydrogenase (acetylating) (1.2.1.10)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y102/00Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
    • C12Y102/07Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with an iron-sulfur protein as acceptor (1.2.7)
    • C12Y102/07005Aldehyde ferredoxin oxidoreductase (1.2.7.5)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01001Alcohol dehydrogenase (1.1.1.1)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00Technologies for the production of fuel of non-fossil origin
    • Y02E50/10Biofuels, e.g. bio-diesel

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
SG11201810031RA 2016-05-14 2017-05-12 Microorganism with modified aldehyde:ferredoxin oxidoreductase activity and related methods SG11201810031RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662336639P 2016-05-14 2016-05-14
PCT/US2017/032564 WO2017200884A1 (en) 2016-05-14 2017-05-12 Microorganism with modified aldehyde:ferredoxin oxidoreductase activity and related methods

Publications (1)

Publication Number Publication Date
SG11201810031RA true SG11201810031RA (en) 2018-12-28

Family

ID=60295016

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201810031RA SG11201810031RA (en) 2016-05-14 2017-05-12 Microorganism with modified aldehyde:ferredoxin oxidoreductase activity and related methods

Country Status (10)

Country Link
US (1) US10294498B2 (ko)
EP (1) EP3464559A4 (ko)
JP (2) JP2019514441A (ko)
KR (2) KR20230044031A (ko)
CN (1) CN109477063A (ko)
CA (1) CA3024114C (ko)
EA (1) EA201892627A1 (ko)
SG (1) SG11201810031RA (ko)
WO (1) WO2017200884A1 (ko)
ZA (1) ZA201807617B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201892627A1 (ru) * 2016-05-14 2019-04-30 Ланцатек, Инк. Микроорганизм с модифицированной активностью альдегид:ферредоксин оксидоредуктазы и связанные способы
US11976314B2 (en) * 2017-08-29 2024-05-07 Gwangju Institute Of Science And Technology Method for converting non-ethanol producing, acetogenic strain to ethanol-producing strain and method for producing ethanol from same ethanol-producing strain by using carbon monoxide
CN109929862B (zh) * 2019-03-14 2022-09-16 云南农业大学 一种从反刍动物瘤胃宏转录组数据筛选纤维素酶基因进行克隆的方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593886A (en) 1992-10-30 1997-01-14 Gaddy; James L. Clostridium stain which produces acetic acid from waste gases
UA72220C2 (uk) 1998-09-08 2005-02-15 Байоенджініерінг Рісорсиз, Інк. Незмішувана з водою суміш розчинник/співрозчинник для екстрагування оцтової кислоти, спосіб одержання оцтової кислоти (варіанти), спосіб анаеробного мікробного бродіння для одержання оцтової кислоти (варіанти), модифікований розчинник та спосіб його одержання
NZ546496A (en) 2006-04-07 2008-09-26 Lanzatech New Zealand Ltd Gas treatment process
US7704723B2 (en) 2006-08-31 2010-04-27 The Board Of Regents For Oklahoma State University Isolation and characterization of novel clostridial species
NZ553984A (en) 2007-03-19 2009-07-31 Lanzatech New Zealand Ltd Alcohol production process
EP2217696B1 (en) 2007-11-13 2015-09-16 Lanzatech New Zealand Limited Novel bacteria and methods of use thereof
WO2009151342A1 (en) 2008-06-09 2009-12-17 Lanzatech New Zealand Limited Production of butanediol by anaerobic microbial fermentation
US8039239B2 (en) 2008-12-16 2011-10-18 Coskata, Inc. Recombinant microorganisms having modified production of alcohols and acids
EP2545178A4 (en) 2010-03-10 2014-06-11 Lanzatech New Zealand Ltd ACIDIFICATION BY FERMENTATION
WO2011114238A2 (en) * 2010-03-18 2011-09-22 Universität Regensburg Shuttle vector based transformation system for pyrococcus furiosus
WO2012024522A2 (en) 2010-08-19 2012-02-23 Lanzatech New Zealand Limited A process for producing chemicals using microbial fermentation of substrates comprising carbon monoxide
CN103282505A (zh) 2010-08-26 2013-09-04 新西兰郎泽科技公司 通过发酵产生乙醇和乙烯的方法
US20110236941A1 (en) 2010-10-22 2011-09-29 Lanzatech New Zealand Limited Recombinant microorganism and methods of production thereof
KR102015672B1 (ko) 2011-02-25 2019-08-29 란자테크 뉴질랜드 리미티드 재조합 미생물 및 이의 용도
CN103582703A (zh) * 2011-03-31 2014-02-12 新西兰郎泽科技公司 一种用于控制丁二醇生产的发酵方法
KR101989641B1 (ko) 2011-09-08 2019-06-14 란자테크 뉴질랜드 리미티드 발효 공정
US9994878B2 (en) 2012-05-30 2018-06-12 Lanzatech New Zealand Limited Recombinant microorganisms and uses therefor
US20130323820A1 (en) 2012-06-01 2013-12-05 Lanzatech New Zealand Limited Recombinant microorganisms and uses therefor
CN113186144A (zh) 2012-06-08 2021-07-30 朗泽科技新西兰有限公司 重组微生物和其用途
US9347076B2 (en) 2012-06-21 2016-05-24 Lanzatech New Zealand Limited Recombinant microorganisms that make biodiesel
IN2015DN01365A (ko) 2012-08-28 2015-07-03 Lanzatech New Zealand Ltd
US20140273115A1 (en) * 2013-03-15 2014-09-18 Lanzatech New Zealand Limited System and method for controlling metabolite production in a microbial fermentation
EP3004362A4 (en) * 2013-06-05 2017-01-11 Lanzatech New Zealand Limited Recombinant microorganisms exhibiting increased flux through a fermentation pathway
US20150275238A1 (en) * 2014-03-28 2015-10-01 University Of Georgia Research Foundation, Inc. Genetically engineered microbes and methods for converting organic acids to alcohols
CN110066718B (zh) * 2014-10-22 2022-09-20 朗泽科技新西兰有限公司 多阶段系统和用于将co转化成乙醇的多阶段生物学方法
BR122023023164A2 (pt) 2015-05-27 2024-03-05 Lanzatech Nz, Inc. Bactéria geneticamente modificada fixadora de c1 capaz de produzir pelo menos um produto derivado de corismato, e, método de fabricação de um produto de fermentação
KR20210037002A (ko) 2015-10-13 2021-04-05 란자테크 뉴질랜드 리미티드 에너지-생성 발효 경로를 포함하는 유전자 조작된 박테리아
EA201892627A1 (ru) * 2016-05-14 2019-04-30 Ланцатек, Инк. Микроорганизм с модифицированной активностью альдегид:ферредоксин оксидоредуктазы и связанные способы

Also Published As

Publication number Publication date
US20170327849A1 (en) 2017-11-16
KR102514023B1 (ko) 2023-03-23
EP3464559A4 (en) 2020-02-12
EP3464559A1 (en) 2019-04-10
WO2017200884A1 (en) 2017-11-23
EA201892627A1 (ru) 2019-04-30
ZA201807617B (en) 2021-04-28
CN109477063A (zh) 2019-03-15
KR20230044031A (ko) 2023-03-31
JP2019514441A (ja) 2019-06-06
US10294498B2 (en) 2019-05-21
CA3024114A1 (en) 2017-11-23
JP2022163046A (ja) 2022-10-25
KR20190017790A (ko) 2019-02-20
CA3024114C (en) 2020-02-04

Similar Documents

Publication Publication Date Title
SG11201805320XA (en) Materials and methods for treatment of amyotrophic lateral sclerosis and/or frontal temporal lobular degeneration
SG11201809040YA (en) Hybrid aerosol-generating element and method for manufacturing a hybrid aerosol-generating element
SG11201810031RA (en) Microorganism with modified aldehyde:ferredoxin oxidoreductase activity and related methods
Nakagawa et al. Total biosynthesis of opiates by stepwise fermentation using engineered Escherichia coli
SG11201801401UA (en) A pharmaceutical composition for use in the treatment or prevention of a c5-related disease and a method for treating or preventing a c5-related disease
SG11201908719QA (en) Biomarkers and car t cell therapies with enhanced efficacy
SG11201908489XA (en) De novo synthesized combinatorial nucleic acid libraries
Murphy et al. Recent advances in fluorination techniques and their anticipated impact on drug metabolism and toxicity
SG11201810179RA (en) Novel crispr enzymes and systems
SG11201804375WA (en) Compositions and methods for internalizing enzymes
SG11201809522WA (en) Method of nucleic acid sequence determination
SG11201806639VA (en) New streptococcal proteases
SG11201810003UA (en) Using programmable dna binding proteins to enhance targeted genome modification
SG11201808799SA (en) Amine-substituted aryl or heteroaryl compounds as ehmt1 and ehmt2 inhibitors
SG11201905673RA (en) A process and system for product recovery and cell recycle
SG11201901371XA (en) Methods for the detection of genomic copy changes in dna samples
SG11201806988UA (en) Improved differentiation method
SG11201808528VA (en) Modified wound dressings
SG11201805504RA (en) Aerosol generating article including a heat-conducting element and a surface treatment
SG11201908478SA (en) Sterilisation method
SG11201908596WA (en) Mmlv reverse transcriptase variants
France et al. The evolving nature of biocatalysis in pharmaceutical research and development
SG11201807537RA (en) Process for the preparation of an antibody-rifamycin conjugate
SG11201808176TA (en) Gene therapy for treating mucopolysaccharidosis type ii
SG11201901203PA (en) Treatment and sustained virologic remission of hiv infection by antibodies to cd4 in haart stabilized patients